Not a good buy right now: the stock is technically strong but stretched (RSI > 70) and sitting near/just above resistance after a sharp up move.
Fundamentals are currently weak (2025/Q3 showed a sharp YoY revenue drop and a move to losses), so the trend is being driven more by price momentum than improving business results.
For an impatient buyer, the risk/reward at ~5.67 is unfavorable versus waiting for either (1) a pullback toward ~5.42–5.18 support or (2) a clean breakout and hold above ~5.81.
Trend: Bullish (SMA_5 > SMA_20 > SMA_200), confirming an established uptrend.
Momentum: MACD histogram is positive (0.0358) and expanding, supportive of continuation.
Overbought/extension: RSI_6 at 71.5 suggests the move is getting stretched and prone to a near-term pullback.
Levels: Pivot ~5.422 (key area to hold on dips); Support S1 ~5.182 / S2 ~5.033.
Resistance: R1 ~5.663 is being tested/cleared in post-market (5.67); next resistance R2 ~5.812 (likely profit-taking zone).
Positive Catalysts
is pressing above R1 (~5.663); a sustained hold could open a push toward ~5.
No negative news flow in the past week (no fresh headline overhang).
Neutral/Negative Catalysts
while trading into resistance increases odds of a pullback.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 136.6M, down -26.14% YoY (meaningful contraction).
Profitability: Net income -8.75M (down -114.85% YoY), indicating a swing deeper into losses.
EPS: -0.11, down -114.67% YoY.
Gross margin: 62.04%, down -9.80% YoY (margin compression trend).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price-target change data was provided, so there is no clear read on recent Wall Street upgrades/downgrades.
Practical takeaway: without visible analyst support and with weakening YoY fundamentals, the “pro” case rests mainly on technical momentum; the “con” case is deteriorating financial performance and lack of confirmatory external sentiment data.
Wall Street analysts forecast GFR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GFR is 5.76 USD with a low forecast of 5.76 USD and a high forecast of 5.76 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast GFR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GFR is 5.76 USD with a low forecast of 5.76 USD and a high forecast of 5.76 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
Current: 5.490
Low
5.76
Averages
5.76
High
5.76
Current: 5.490
Low
5.76
Averages
5.76
High
5.76
BMO Capital
Tariq Saad
Outperform -> Market Perform
downgrade
$8
AI Analysis
2025-09-22
Reason
BMO Capital
Tariq Saad
Price Target
$8
AI Analysis
2025-09-22
downgrade
Outperform -> Market Perform
Reason
BMO Capital analyst Tariq Saad downgraded Greenfire Resources to Market Perform from Outperform with an unchanged price target of C$8. The firm expects the company to \"materially outspend\" its cash flow in 2026, driving leverage higher. It believes the shares are due for a \"breather.\"
